Precision Oncology
Platforms using natural language processing are showing promise in scanning patients' records for biomarkers and other enrollment criteria for clinical trials.
A2 Biotherapeutics Raises $80M in Series C Funding
The firm will use the funding to advance ongoing clinical trials of its autologous cell therapies for solid tumors.
Ovation.io Collecting WGS, Clinical Data From 8,500 Patients on GLP-1 Meds
The firm said it struck a three-year licensing deal with a top pharmaceutical company that will use the data to advance GLP-1 receptor agonist research.
Intellia Cuts AATD Gene Insertion Program, 27 Percent of Workforce in Strategic Reorganization
These moves will enable the gene-editing company to focus resources on late-stage programs as it aims to launch a commercial product by 2027, it said.
Scipher Medicine, Omny Health Partner to Integrate Test Data Into EMR Network
The two firms are hopeful that integrating their respective transcriptomic and clinical datasets will help in the development of new targeted therapies.
Jan 8, 2025
XyloCor Raises $67.5M in Series B Financing
Jan 6, 2025
Dec 30, 2024